In a study of 60 breast cancers [59], stratified by familial history and known BRCA status, there were significantly higher levels of VEGF and Angiopoietin-1 and Angiopoietin-2, two other angiogenic factors involved in vessel remodelling in patients with BRCA1/2 mutations. This evidence concerns the gene BRCA1 and breast cancer.